within Pharmacolibrary.Drugs.ATC.C;

model C05AX01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-08,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 1e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C05AX01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Aluminium preparations are pharmaceutical agents containing aluminium compounds, historically used primarily for their astringent and haemostatic properties in topical haemorrhoidal and anorectal medications. They are also used as antacids and adjuvants in some vaccines, but topical use is mostly limited today, and most are not systemically absorbed or clinically significant. Not routinely used as systemic drugs and not widely approved as systemic medications at present.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals after topical or oral administration, as no data on systemic pharmacokinetics for C05AX01 aluminium preparations are available in the scientific literature.</p><h4>References</h4><ol><li><p>Lvov, YM, et al., &amp; Fakhrullin, RF (2016). The application of halloysite tubule nanoclay in drug delivery. <i>Expert opinion on drug delivery</i> 13(7) 977–986. DOI:<a href=\"https://doi.org/10.1517/17425247.2016.1169271\">10.1517/17425247.2016.1169271</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27027933/\">https://pubmed.ncbi.nlm.nih.gov/27027933</a></p></li><li><p>Santos, AC, et al., &amp; Agarwal, A (2018). Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold. <i>Advances in colloid and interface science</i> 257 58–70. DOI:<a href=\"https://doi.org/10.1016/j.cis.2018.05.007\">10.1016/j.cis.2018.05.007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29887382/\">https://pubmed.ncbi.nlm.nih.gov/29887382</a></p></li><li><p>de Ligt, R, et al., &amp; Vaes, WHJ (2018). Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a . <i>Clinical and translational science</i> 11(6) 573–581. DOI:<a href=\"https://doi.org/10.1111/cts.12579\">10.1111/cts.12579</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30052317/\">https://pubmed.ncbi.nlm.nih.gov/30052317</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C05AX01;
